Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 3 Vitamin D Deficiency 1 Smoldering Multiple Myeloma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Plasmacytoma 1 POEMS Syndrome 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Leukemia-Lymphoma, Adult T-Cell 1 Immunoblastic Lymphadenopathy 1

Interventions

gallium Ga 68 dotatate 2 etoposide phosphate 2 Vincristine 2 Thiotepa 2 Temozolomide 2 Mesna 2 Magnetic Resonance Spectroscopy 2 Etoposide 2 Cyclophosphamide 2 Carboplatin 2 3-Iodobenzylguanidine 2 naxitamab 1 fludarabine 1 eliglustat 1 Vaccines, DNA 1 Topotecan 1 Tamoxifen 1 Rituximab 1 Lenalidomide 1 Isotretinoin 1 Irinotecan 1 Ifosfamide 1 Hydrocortisone 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Granulocyte Colony-Stimulating Factor 1 Ga(III)-DOTATOC 1 Filgrastim 1 Doxorubicin 1 Cisplatin 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Neuroblastoma × Lenalidomide × Clear all

NCT04049864 2022-03-02

DNA Vaccination Against Neuroblastoma

Belarusian Research Center for Pediatric Oncology, Hematology and Immunology

Phase EARLY_PHASE1 Unknown

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡